Armistice Capital, LLC’s Madrigal Pharmaceuticals Inc Position
Does Armistice Capital, LLC own Madrigal Pharmaceuticals Inc (MDGL)? Yes — 264.6K shares worth $139M (+2.46% of its 13F portfolio) as of Q1 2026, down from 265.7K shares the prior filed quarter.
Position Value
$139M
Q1 2026
Shares
264.6K
% of Portfolio
+2.46%
Quarters Held
25
currently held
Position History MDGL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 264.6K | $139M | +2.46% |
| Q4 2025 | 265.7K | $155M | +1.84% |
| Q3 2025 | 120.0K | $55M | +0.82% |
| Q2 2025 | 124.0K | $38M | +0.65% |
| Q1 2025 | 135.9K | $45M | +0.67% |
| Q4 2024 | 100.0K | $31M | +0.42% |
| Q3 2024 | 49.9K | $11M | +0.17% |
| Q2 2024 | 150.0K | $42M | +0.53% |
| Q1 2024 | 168.0K | $45M | +0.59% |
| Q4 2023 | 50.0K | $12M | +0.16% |
| Q3 2023 | 108.0K | $16M | +0.24% |
| Q2 2023 | 136.0K | $31M | +0.45% |
| Q1 2023 | 276.0K | $67M | +0.96% |
| Q4 2022 | 208.0K | $60M | +1.05% |
| Q3 2022 | 1.24M | $80M | +1.39% |
| Q2 2022 | 1.10M | $79M | +1.37% |
| Q1 2022 | 978.0K | $96M | +1.86% |
| Q4 2021 | 1.12M | $95M | +1.56% |
| Q3 2021 | 1.04M | $83M | +1.40% |
| Q2 2021 | 592.0K | $58M | +1.03% |
| Q1 2021 | 350.0K | $41M | +0.94% |
| Q4 2020 | 316.0K | $35M | +1.57% |
| Q3 2020 | 278.0K | $33M | +1.20% |
| Q2 2020 | 248.0K | $28M | +1.23% |
| Q1 2020 | 216.0K | $14M | +0.89% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Armistice Capital, LLC’s full portfolio or all institutional holders of MDGL.